Merck KGaA

Last price: €150.35 Updated: 2 years ago 52w range: €134.30 to €189.35 52w change: 12.00% to -21.00% Forward PE: 16.87 Trailing EPS: 6.66 50d average: €148.06 (2%) 200d average: €155.29 (-3%)
Open: €151.35 Previous close: €152.40 Change: -€2.05 (-1.35%) Day high: €151.60 Day low: €149.55 Volume: 139.70 thousand Avg. vol 3m: 377.01 thousand
XETRA ETR:MRK Cap: 65.37 billion Shares outstanding: 129.2 million Price hint: 2 Price to book: 2.32 Annual dividend rate: 2.20 Annual dividend yield: 0.01 €2.20 dividend 3 years ago
Yahoo Quote

Ask about this stock

Ask a question.

Not personal financial advice.
Research

MRK.DE

Merck KGaA is a multinational pharmaceutical, chemical, and life sciences company headquartered in Darmstadt, Germany. It is one of the world's oldest operating chemical and pharmaceutical companies, as well-established as it is globally recognized.

Here's the lowdown on Merck KGaA:

1. Business Segments: Merck KGaA operates through three business sectors—Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, manufactures, and markets products to treat cancer and multiple sclerosis, among other diseases. The Life Science sector offers specialty consumables, software, instruments, and services for researchers in biotech and pharmaceutical industries. The Performance Material sector develops specialty chemicals for several complex applications.

2. Global Presence: With its operations spread over 66 countries, the company has a widely diversified customer base, allowing it to mitigate risks associated with overdependence on a single region or market.

3. Research And Development: Merck KGaA invests heavily in R&D, a crucial factor in the pharmaceutical industry. Its impressive pipeline of drugs and the success rate of converting these drugs into marketable products can potentially provide a competitive edge.

4. Financials: The company has shown stable financial performance over the years. However, it's crucial to understand that the pharma sector is heavily dependent on big blockbuster products that require substantial investment and time to develop. The sector also carries regulatory risks.

5. Dividend Policy: Merck KGaA has a history of paying dividends, making it attractive to investors seeking regular income.

6. Risks: Merck KGaA also faces risks, similar to any pharmaceutical company. These include competition, pricing pressure, regulatory issues, intellectual property rights, and product liability claims.

7. Stock Performance: Merck KGaA's stock has historically shown steady growth, but it's important to note that stock market performance can be influenced by various external factors.

Before deciding to invest, I strongly advise further in-depth analysis of the company, considering both its financial statement and its potential for future growth. Please also consider your personal financial goals and risk tolerance. Always diversify your investments to spread the risk.

1 Feb 2024

Notes
Note URL